Background: Ischemia-reperfusion injury (IRI) secondary to acute limb ischemia is a complex clinical phenomenon induced by a variety of pathologies, including arterial embolization, arterial thrombosis, vascular trauma, advanced peripheral vascular disease, traumatic crush injuries, and/or prolonged tourniquet application. The restoration of blood flow and oxygen to the limb after an ischemic period, while necessary, is ultimately the driving force of IRI. The exaggerated inflammation, oxidative stress, and tissue damage caused by IRI often lead to limb dysfunction, limb loss, multi-organ failure, and/or death. While no gold-standard therapy currently exists, various in vitro and in vivo models have been developed to explore potential therapeutic strategies. Currently, pharmacological agents with anti-inflammatory and/or antioxidant properties, as well as non-pharmacological strategies, have been investigated, and some agents show promise in mitigating the effects of lower extremity ischemia-reperfusion injury (IRI). Purpose: In this review article, we provide a comprehensive overview of the pathophysiology of IRI, discuss the local and systemic effects of IRI, and examine the experimental models used to investigate IRI. We also outline the current in vitro and in vivo pharmacological and non-pharmacological interventions studied to reduce IRI.
ZhaoYFengQHuangZ, et al.Simvastatin inhibits inflammation in ischemia-reperfusion injury. Inflammation. 2014;37(5):1865-1875. doi:10.1007/s10753-014-9918-x
2.
HsuKYTsaiPSLeeJJWangTYHuangCJ. Platonin mitigates acute lung injury induced by bilateral lower limb ischemia-reperfusion in rats. J Surg Res. 2011;167(2):e255-e262. doi:10.1016/j.jss.2010.03.075
3.
GranfeldtA. Organ dysfunction following regional and global ischemia/reperfusion. Intervention with postconditioning and adenocaine. Dan Med J. 2012;59(8):B4496.
4.
LalandeSHemingwayHWJarrardCP, et al.Influence of ischemia-reperfusion injury on endothelial function in men and women with similar serum estradiol concentrations. Am J Physiol Regul Integr Comp Physiol. 2021;321(2):R273-R278. doi:10.1152/ajpregu.00147.2021
5.
TuHZhangDQianJ, et al.A comparison of acute mouse hindlimb injuries between tourniquet- and femoral artery ligation-induced ischemia-reperfusion. Injury. 2021;52(11):3217-3226. doi:10.1016/j.injury.2021.09.002
6.
AkarsuMSaygunOAydinurazK, et al.The effects of simvastatin on ischemia reperfusion injury in an experimental colon anastomosis model. Indian J Surg. 2017;79(5):390-395. doi:10.1007/s12262-016-1493-y
7.
CowledPFitridgeR. Pathophysiology of reperfusion injury. In: FitridgeRThompsonM, eds. Mechanisms of Vascular Disease: A Reference Book for Vascular Specialists. Berlin: Springer; 2011.
8.
EltzschigHKEckleT. Ischemia and reperfusion--from mechanism to translation. Nat Med. 2011;17(11):1391-1401. doi:10.1038/nm.2507
9.
CorrickRMTuHZhangD, et al.Dexamethasone protects against tourniquet-induced acute ischemia-reperfusion injury in mouse hindlimb. Front Physiol. 2018;9:244. doi:10.3389/fphys.2018.00244
10.
CrawfordRSHashmiFFJonesJE, et al.A novel model of acute murine hindlimb ischemia. Am J Physiol Heart Circ Physiol. 2007;292(2):H830-H837. doi:10.1152/ajpheart.00581.2006
11.
XiangYYeSCaiC, et al.Salvianolic acid a attenuates limb ischemia/reperfusion injury in skeletal muscle of rats. Biomed Pharmacother. 2018;97:551-556. doi:10.1016/j.biopha.2017.10.094
12.
GillaniSCaoJSuzukiTHakDJ. The effect of ischemia reperfusion injury on skeletal muscle. Injury. 2012;43(6):670-675. doi:10.1016/j.injury.2011.03.008
13.
PeresECVictorioJANunes-SouzaV, et al.Simvastatin protects against intestinal ischemia/reperfusion-induced pulmonary artery dysfunction. Life Sci. 2022;306:120851. doi:10.1016/j.lfs.2022.120851
ApichartpiyakulPShinlapawittayatornKRerkasemKChattipakornSCChattipakornN. Mechanisms and interventions on acute lower limb ischemia/reperfusion injury: a review and insights from cell to clinical investigations. Ann Vasc Surg. 2022;86:452-481. doi:10.1016/j.avsg.2022.04.040
16.
Andrade-SilvaARRamalhoFSRamalhoLN, et al.Effect of NFkappaB inhibition by CAPE on skeletal muscle ischemia-reperfusion injury. J Surg Res. 2009;153(2):254-262. doi:10.1016/j.jss.2008.04.009
17.
JunejaAGarutharaMTalathiSRaoALandisGEtkinY. Predictors of poor outcomes after lower extremity revascularization for acute limb ischemia. Vascular. 2023;32:17085381231154290. doi:10.1177/17085381231154290
18.
AtahanEErgunYKurutasEBAliciT. Protective effect of zinc aspartate on long-term ischemia-reperfusion injury in rat skeletal muscle. Biol Trace Elem Res. 2010;137(2):206-215. doi:10.1007/s12011-009-8568-6
19.
LutzJThurmelKHeemannU. Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation. J Inflamm. 2010;7:27. doi:10.1186/1476-9255-7-27
20.
LindBMorcosOFerralH, et al.Endovascular strategies in the management of acute limb ischemia. Vasc Specialist Int. 2019;35(1):4-9. doi:10.5758/vsi.2019.35.1.4
ZhangMLiuQMengH, et al.Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets. Signal Transduct Targeted Ther. 2024;9(1):12. doi:10.1038/s41392-023-01688-x
23.
AkahaneHGKGomesRZPaludoKSLinharesFLopesL. The influence of allopurinol and post-conditioning on lung injuries induced by lower-limb ischemia and reperfusion in Wistar rats. Acta Cir Bras. 2017;32(9):746-754. doi:10.1590/s0102-865020170090000007
JiaYZLiuJWangGQ, et al.HIG1 domain family member 1A is a crucial regulator of disorders associated with hypoxia. Mitochondrion. 2023;69:171-182. doi:10.1016/j.mito.2023.02.009
26.
Gonzalez-AvilaGSommerBFlores-SotoEAquino-GalvezA. Hypoxic effects on matrix metalloproteinases’ expression in the tumor microenvironment and therapeutic perspectives. Int J Mol Sci. 2023;24(23):16887. doi:10.3390/ijms242316887
27.
DoeMRAscanoJMKaurMColeMD. Myc posttranscriptionally induces HIF1 protein and target gene expression in normal and cancer cells. Cancer Res. 2012;72(4):949-957. doi:10.1158/0008-5472.CAN-11-2371
DrozdovskaSZanouNLavierJMazzolaiLMilletGPPellegrinM. Moderate effects of hypoxic training at low and supramaximal intensities on skeletal muscle metabolic gene expression in mice. Metabolites. 2023;13(10):1103. doi:10.3390/metabo13101103
30.
NakayamaKKataokaN. Regulation of gene expression under hypoxic conditions. Int J Mol Sci. 2019;20(13):3278. doi:10.3390/ijms20133278
31.
FengYXiongYQiaoTLiXJiaLHanY. Lactate dehydrogenase A: a key player in carcinogenesis and potential target in cancer therapy. Cancer Med. 2018;7(12):6124-6136. doi:10.1002/cam4.1820
32.
CavadasMAMesnieresMCrifoB, et al.REST is a hypoxia-responsive transcriptional repressor. Sci Rep. 2016;6:31355. doi:10.1038/srep31355
33.
GreijerAEvan der GroepPKemmingD, et al.Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol. 2005;206(3):291-304. doi:10.1002/path.1778
34.
ChandelNSTrzynaWCMcClintockDSSchumackerPT. Role of oxidants in NF-κB activation and TNF-α gene transcription induced by hypoxia and endotoxin. J Immunol. 2000;165(2):1013-1021. doi:10.4049/jimmunol.165.2.1013
35.
Panisello-RoselloARosello-CatafauJ. Molecular mechanisms and pathophysiology of ischemia-reperfusion injury. Int J Mol Sci. 2018;19(12):4093. doi:10.3390/ijms19124093
36.
Panisello-RoselloARosello-CatafauJAdamR. New insights in molecular mechanisms and pathophysiology of ischemia-reperfusion injury 2.0: an updated overview. Int J Mol Sci. 2020;22(1):28. doi:10.3390/ijms22010028
37.
PhiliposeSKonyaVSreckovicI, et al.The prostaglandin E2 receptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formation. Arterioscler Thromb Vasc Biol. 2010;30(12):2416-2423. doi:10.1161/ATVBAHA.110.216374
38.
KatusicZSSanthanamAVHeT. Vascular effects of prostacyclin: does activation of PPARdelta play a role?Trends Pharmacol Sci. 2012;33(10):559-564. doi:10.1016/j.tips.2012.05.005
39.
KalinskiP. Regulation of immune responses by prostaglandin E2. J Immunol. 2012;188(1):21-28. doi:10.4049/jimmunol.1101029
40.
DorrisSLPeeblesRSJr. PGI2 as a regulator of inflammatory diseases. Mediat Inflamm. 2012;2012:926968. doi:10.1155/2012/926968
41.
BackMSakataKQiuHHaeggstromJZDahlenSE. Endothelium-dependent vascular responses induced by leukotriene B4. Prostag Other Lipid Mediat. 2007;83(3):209-212. doi:10.1016/j.prostaglandins.2007.01.008
42.
Di GennaroAKenneEWanMSoehnleinOLindbomLHaeggstromJZ. Leukotriene B4-induced changes in vascular permeability are mediated by neutrophil release of heparin-binding protein (HBP/CAP37/azurocidin). FASEB J. 2009;23(6):1750-1757. doi:10.1096/fj.08-121277
43.
SalaAZariniSBollaM. Leukotrienes: lipid bioeffectors of inflammatory reactions. Biochemistry. 1998;63(1):84-92.
44.
DuahEAdapalaRKAl-AzzamN, et al.Cysteinyl leukotrienes regulate endothelial cell inflammatory and proliferative signals through CysLT(2) and CysLT(1) receptors. Sci Rep. 2013;3:3274. doi:10.1038/srep03274
45.
Sanchez-GalanEGomez-HernandezAVidalC, et al.Leukotriene B4 enhances the activity of nuclear factor-kappaB pathway through BLT1 and BLT2 receptors in atherosclerosis. Cardiovasc Res. 2009;81(1):216-225. doi:10.1093/cvr/cvn277
46.
CummingsHELiuTFengC, et al.Cutting edge: Leukotriene C4 activates mouse platelets in plasma exclusively through the type 2 cysteinyl leukotriene receptor. J Immunol. 2013;191(12):5807-5810. doi:10.4049/jimmunol.1302187
KondetiVAl-AzzamNDuahEThodetiCKBoyceJAParuchuriS. Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell-dependent manner through cysteinyl leukotriene receptor 1 and E-prostanoid receptor 3. J Allergy Clin Immunol. 2016;137(1):289-298. doi:10.1016/j.jaci.2015.06.030
49.
ChenH. Role of thromboxane A(2) signaling in endothelium-dependent contractions of arteries. Prostag Other Lipid Mediat. 2018;134:32-37. doi:10.1016/j.prostaglandins.2017.11.004
50.
OzenGAljesriKCelikZ, et al.Mechanism of thromboxane receptor-induced vasoconstriction in human saphenous vein. Prostag Other Lipid Mediat. 2020;151:106476. doi:10.1016/j.prostaglandins.2020.106476
51.
CapraVBackMAngiolilloDJCattaneoMSakariassenKS. Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation. J Thromb Haemostasis. 2014;12(2):126-137. doi:10.1111/jth.12472
52.
GabrielsenAQiuHBackM, et al.Thromboxane synthase expression and thromboxane A2 production in the atherosclerotic lesion. J Mol Med (Berl). 2010;88(8):795-806. doi:10.1007/s00109-010-0621-6
53.
HeJKhanUZQingLWuPTangJ. Improving the ischemia-reperfusion injury in vascularized composite allotransplantation: clinical experience and experimental implications. Front Immunol. 2022;13:998952. doi:10.3389/fimmu.2022.998952
54.
OmoriKKidaTHoriMOzakiHMurataT. Multiple roles of the PGE2 -EP receptor signal in vascular permeability. Br J Pharmacol. 2014;171(21):4879-4889. doi:10.1111/bph.12815
55.
McEverRP. Selectins: initiators of leucocyte adhesion and signalling at the vascular wall. Cardiovasc Res. 2015;107(3):331-339. doi:10.1093/cvr/cvv154
56.
SinghVKaurRKumariPPasrichaCSinghR. ICAM-1 and VCAM-1: gatekeepers in various inflammatory and cardiovascular disorders. Clin Chim Acta. 2023;548:117487. doi:10.1016/j.cca.2023.117487
57.
Nemcovsky AmarDEpshteinMKorinN. Endothelial cell activation in an embolic ischemia-reperfusion injury microfluidic model. Micromachines. 2019;10(12):857. doi:10.3390/mi10120857
58.
NadkarniNAAriasEFangR, et al.Platelet endothelial cell adhesion molecule (PECAM/CD31) blockade modulates neutrophil recruitment patterns and reduces infarct size in experimental ischemic stroke. Am J Pathol. 2022;192(11):1619-1632. doi:10.1016/j.ajpath.2022.07.008
59.
CollardCDGelmanS. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology. 2001;94(6):1133-1138. doi:10.1097/00000542-200106000-00030
60.
ZhangJHuangSZhuZGattALiuJ. E-selectin in vascular pathophysiology. Front Immunol. 2024;15:1401399. doi:10.3389/fimmu.2024.1401399
61.
DryschMWallnerCSchmidtSV, et al.An optimized low-pressure tourniquet murine hind limb ischemia reperfusion model: inducing acute ischemia reperfusion injury in C57BL/6 wild type mice. PLoS One. 2019;14(1):e0210961. doi:10.1371/journal.pone.0210961
62.
WuMYYiangGTLiaoWT, et al.Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem. 2018;46(4):1650-1667. doi:10.1159/000489241
63.
YazdiASGhoreschiK. The Interleukin-1 family. Adv Exp Med Biol. 2016;941:21-29. doi:10.1007/978-94-024-0921-5_2
64.
SchettGDayerJMMangerB. Interleukin-1 function and role in rheumatic disease. Nat Rev Rheumatol. 2016;12(1):14-24. doi:10.1038/nrrheum.2016.166
65.
PyrillouKBurzynskiLCClarkeMCH. Alternative pathways of IL-1 activation, and its role in health and disease. Front Immunol. 2020;11:613170. doi:10.3389/fimmu.2020.613170
66.
GrebenciucovaEVanHaerentsS. Interleukin 6: at the interface of human health and disease. Front Immunol. 2023;14:1255533. doi:10.3389/fimmu.2023.1255533
67.
AliyuMZohoraFTAnkaAU, et al.Interleukin-6 cytokine: an overview of the immune regulation, immune dysregulation, and therapeutic approach. Int Immunopharmacol. 2022;111:109130. doi:10.1016/j.intimp.2022.109130
68.
Schmidt-ArrasDRose-JohnS. IL-6 pathway in the liver: from physiopathology to therapy. J Hepatol. 2016;64(6):1403-1415. doi:10.1016/j.jhep.2016.02.004
69.
BodeJGAlbrechtUHaussingerDHeinrichPCSchaperF. Hepatic acute phase proteins--regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-kappaB-dependent signaling. Eur J Cell Biol. 2012;91(6-7):496-505. doi:10.1016/j.ejcb.2011.09.008
70.
MatsushimaKYangDOppenheimJJ. Interleukin-8: an evolving chemokine. Cytokine. 2022;153:155828. doi:10.1016/j.cyto.2022.155828
71.
SmithRJSamLMLeachKLJustenJM. Postreceptor events associated with human neutrophil activation by interleukin-8. J Leukoc Biol. 1992;52(1):17-26. doi:10.1002/jlb.52.1.17
72.
JafferUWadeRGGourlayT. Cytokines in the systemic inflammatory response syndrome: a review. HSR Proc Intensive Care Cardiovasc Anesth. 2010;2(3):161-175.
73.
PokharelSMChiokKShilNKMohantyIBoseS. Tumor necrosis factor-alpha utilizes MAPK/NFkappaB pathways to induce cholesterol-25 hydroxylase for amplifying pro-inflammatory response via 25-hydroxycholesterol-integrin-FAK pathway. PLoS One. 2021;16(9):e0257576. doi:10.1371/journal.pone.0257576
74.
SoaresROSLosadaDMJordaniMCEvoraPCastroESO. Ischemia/reperfusion injury revisited: an overview of the latest pharmacological strategies. Int J Mol Sci. 2019;20(20):5034. doi:10.3390/ijms20205034
ArpaciAHKoksalZYigmanZ, et al.Effect of fullerenol C60 on lung and renal tissue in lower extremity ischemia-reperfusion injury in sevoflurane-treated rats. Mol Med Rep. 2024;29(3):54. doi:10.3892/mmr.2024.13178
77.
KasepaluTKuusikKLepnerU, et al.Remote ischaemic preconditioning reduces kidney injury biomarkers in patients undergoing open surgical lower limb revascularisation: a randomised trial. Oxid Med Cell Longev. 2020;2020:1-8. doi:10.1155/2020/7098505
78.
LeungCHCaldaroneCAWangF, et al.Remote ischemic conditioning prevents lung and liver injury after hemorrhagic shock/resuscitation: Potential role of a humoral plasma factor. Ann Surg. 2015;261(6):1215-1225. doi:10.1097/SLA.0000000000000877
79.
BruggerJSchickMABrockRW, et al.Carbon monoxide has antioxidative properties in the liver involving p38 MAP kinase pathway in a murine model of systemic inflammation. Microcirculation. 2010;17(7):504-513. doi:10.1111/j.1549-8719.2010.00044.x
80.
GaoXBiYChiK, et al.Glycine-nitronyl nitroxide conjugate protects human umbilical vein endothelial cells against hypoxia/reoxygenation injury via multiple mechanisms and ameliorates hind limb ischemia/reperfusion injury in rats. Biochem Biophys Res Commun. 2017;488(1):239-246. doi:10.1016/j.bbrc.2017.05.053
81.
MiLZhangYXuY, et al.HMGB1/RAGE pro-inflammatory axis promotes vascular endothelial cell apoptosis in limb ischemia/reperfusion injury. Biomed Pharmacother. 2019;116:109005. doi:10.1016/j.biopha.2019.109005
82.
WangFQiYGaoYWangZShenXWuH. Syringic acid suppresses ferroptosis of skeletal muscle cells to alleviate lower limb ischemia/reperfusion injury in mice via the HMGB1 pathway. Chem Biol Drug Des. 2023;102(6):1387-1398. doi:10.1111/cbdd.14326
83.
SchlagMGClarkeSCarsonMWHarrisKAPotterRF. The effect of mannitol versus dimethyl thiourea at attenuating ischemia/reperfusion-induced injury to skeletal muscle. J Vasc Surg. 1999;29(3):511-521. doi:10.1016/s0741-5214(99)70280-6
84.
WilsonHMWeliksonRELuoJ, et al.Can cytoprotective cobalt protoporphyrin protect skeletal muscle and muscle-derived stem cells from ischemic injury?Clin Orthop Relat Res. 2015;473(9):2908-2919. doi:10.1007/s11999-015-4332-8
85.
BilgicMIAltunGCakiciHGiderogluKSakaG. The protective effect of montelukast against skeletal muscle ischemia reperfusion injury: an experimental rat model. Ulus Travma Acil Cerrahi Derg. 2018;24(3):185-190. doi:10.5505/tjtes.2017.22208
86.
KoksalCBozkurtAKCangelU, et al.Attenuation of ischemia/reperfusion injury by N-acetylcysteine in a rat hind limb model. J Surg Res. 2003;111(2):236-239. doi:10.1016/s0022-4804(03)00094-5
87.
ErolKEYSKucukUKucukL. Effect of pheniramine maleate on rat skeletal muscle ischemia-reperfusion injury. Ulus Travma Acil Cerrahi Derg. 2022;28(12):1667-1673. doi:10.14744/tjtes.2021.00312; Feniramin maleatin sican iskelet kasindaki iskemi reperfuzyon hasarina etkisi.
88.
TakhtfooladiHTakhtfooladiMMoayerFMobarakehS. Melatonin attenuates lung injury in a hind limb ischemia-reperfusion rat model. Rev Port Pneumol. 2015;21(1):30-35. doi:10.1016/j.rppnen.2014.01.010
89.
WangHShiM-JHuZ-QMiaoLCaiH-SZhangR-P. Effect of miR-206 on lower limb ischemia–reperfusion injury in rat and its mechanism. Sci Rep. 2023;13(1):21574. doi:10.1038/s41598-023-48858-z
90.
ZhaoXLiuYWangL, et al.Oridonin attenuates hind limb ischemia-reperfusion injury by modulating Nrf2-mediated oxidative stress and NLRP3-mediated inflammation. J Ethnopharmacol. 2022;292:115206. doi:10.1016/j.jep.2022.115206
91.
SunQWuYZhaoFWangJ. Maresin 1 ameliorates lung ischemia/reperfusion injury by suppressing oxidative stress via activation of the Nrf-2-mediated HO-1 signaling pathway. Oxid Med Cell Longev. 2017;2017:9634803. doi:10.1155/2017/9634803
92.
CuiLCaoWXiaYLiX. Ulinastatin alleviates cerebral ischemia-reperfusion injury in rats by activating the Nrf-2/HO-1 signaling pathway. Ann Transl Med. 2020;8(18):1136. doi:10.21037/atm-20-5115
93.
HoriKTsujiiMIinoT, et al.Protective effect of edaravone for tourniquet-induced ischemia-reperfusion injury on skeletal muscle in murine hindlimb. BMC Muscoskelet Disord. 2013;14:113. doi:10.1186/1471-2474-14-113
94.
CruzMP. Edaravone (radicava): a novel neuroprotective agent for the treatment of amyotrophic lateral sclerosis. P T. 2018;43(1):25-28.
95.
SasakiMNakanumaY. Stress-induced cellular responses and cell death mechanisms during inflammatory cholangiopathies. Clin Res Hepatol Gastroenterol. 2017;41(2):129-138. doi:10.1016/j.clinre.2016.08.002
96.
ErgunYKilincMAralMHedefAKayaE. Protective effect of epigallocatechin gallate in ischemia-reperfusion injury of rat skeletal muscle. J Surg Res. 2020;247:1-7. doi:10.1016/j.jss.2019.11.004
HeJHeLLuFGengBXiaY. Low-molecular-weight heparin calcium attenuates the tourniquet-induced ischemia-reperfusion injury in rats. Injury. 2021;52(8):2068-2074. doi:10.1016/j.injury.2021.03.006
99.
DuruSKocaUOztekinS, et al.Antithrombin III pretreatment reduces neutrophil recruitment into the lung and skeletal muscle tissues in the rat model of bilateral lower limb ischemia and reperfusion: a pilot study. Acta Anaesthesiol Scand. 2005;49(8):1142-1148. doi:10.1111/j.1399-6576.2005.00764.x
100.
KankoMMaralHAkbasMH, et al.Protective effects of clopidogrel on oxidant damage in a rat model of acute ischemia. Tohoku J Exp Med. 2005;205(2):133-139. doi:10.1620/tjem.205.133
101.
SilveiraAADominicalVMLazariniMCostaFFConranN. Simvastatin abrogates inflamed neutrophil adhesive properties, in association with the inhibition of Mac-1 integrin expression and modulation of rho kinase activity. Inflamm Res. 2013;62(2):127-132. doi:10.1007/s00011-012-0579-7
102.
ChenWHChenCHHsuMCChangRWWangCHLeeTS. Advances in the molecular mechanisms of statins in regulating endothelial nitric oxide bioavailability: interlocking biology between eNOS activity and L-arginine metabolism. Biomed Pharmacother. 2024;171:116192. doi:10.1016/j.biopha.2024.116192
103.
TuJLiWZhangY, et al.Simvastatin inhibits IL-1beta-induced apoptosis and extracellular matrix degradation by suppressing the NF-kB and MAPK pathways in nucleus pulposus cells. Inflammation. 2017;40(3):725-734. doi:10.1007/s10753-017-0516-6
CivelekAAkKKurtkayaO, et al.Effect of a low molecular weight heparin molecule, dalteparin, on cellular apoptosis and inflammatory process in an incisional wound-healing model. Surg Today. 2007;37(5):406-411. doi:10.1007/s00595-006-3421-4
106.
BiWLiXBiY, et al.Novel TEMPO-PEG-RGDs conjugates remediate tissue damage induced by acute limb ischemia/reperfusion. J Med Chem. 2012;55(9):4501-4505. doi:10.1021/jm201381w
107.
LeeDBaeSHongD, et al.H2O2-responsive molecularly engineered polymer nanoparticles as ischemia/reperfusion-targeted nanotherapeutic agents. Sci Rep. 2013;3:2233. doi:10.1038/srep02233
108.
ZhongJSunYHanY, et al.Hydrogen sulfide-loaded microbubbles combined with ultrasound mediate thrombolysis and simultaneously mitigate ischemia-reperfusion injury in a rat hindlimb model. J Thromb Haemostasis. 2021;19(3):738-752. doi:10.1111/jth.15110
109.
Zuluaga TamayoMChoudatLAid-LaunaisR, et al.Astaxanthin complexes to attenuate muscle damage after in vivo femoral ischemia-reperfusion. Mar Drugs. 2019;17(6):354. doi:10.3390/md17060354
110.
OzerAErelSKucukA, et al.Evaluation of the effect of enriched hydrogen saline solution on distant organ (lung) damage in skeletal muscle ischemia reperfusion in rats. Sci Prog. 2024;107(2):368504241257060. doi:10.1177/00368504241257060
111.
FlahertyDCHoxhaBSunJ, et al.Pyruvate-enriched resuscitation protects hindlimb muscle from ischemia-reperfusion injury. Mil Med. 2010;175(12):1020-1026. doi:10.7205/milmed-d-10-00097
112.
HayashiMObaraHMatsudaS, et al.Protective effects of hydrogen gas inhalation for hindlimb ischaemia-reperfusion injury in a mouse model. Eur J Vasc Endovasc Surg. 2024;68(1):120-128. doi:10.1016/j.ejvs.2024.01.081
113.
HammersDWSarathyAPhamCBDrinnanCTFarrarRPSuggsLJ. Controlled release of IGF-I from a biodegradable matrix improves functional recovery of skeletal muscle from ischemia/reperfusion. Biotechnol Bioeng. 2012;109(4):1051-1059. doi:10.1002/bit.24382
114.
KocmanEAOzatikOSahinA, et al.Effects of ischemic preconditioning protocols on skeletal muscle ischemia-reperfusion injury. J Surg Res. 2015;193(2):942-952. doi:10.1016/j.jss.2014.09.032
115.
WangWZBaynosaRCZamboniWA. Therapeutic interventions against reperfusion injury in skeletal muscle. J Surg Res. 2011;171(1):175-182. doi:10.1016/j.jss.2011.07.015
116.
HarkinDWBarrosDSaAAMcCallionKHoperMCampbellFC. Ischemic preconditioning before lower limb ischemia--reperfusion protects against acute lung injury. J Vasc Surg. 2002;35(6):1264-1273. doi:10.1067/mva.2002.121981
117.
OlgunerCKocaUKarA, et al.Ischemic preconditioning attenuates the lipid peroxidation and remote lung injury in the rat model of unilateral lower limb ischemia reperfusion. Acta Anaesthesiol Scand. 2006;50(2):150-155. doi:10.1111/j.1399-6576.2006.00938.x
118.
GuillotMCharlesALLejayA, et al.Deleterious effects of remote ischaemic per-conditioning during lower limb ischaemia-reperfusion in mice. Eur J Vasc Endovasc Surg. 2021;62(6):953-959. doi:10.1016/j.ejvs.2021.06.032
119.
SongSQGanHLZhangJQFengLSunJCWangSX. Post-conditioning through lower limb ischemia-reperfusion can alleviate lung ischemia-reperfusion injury. Int J Clin Exp Med. 2015;8(9):14953-14961.
120.
GyurkovicsEAranyiPStanglR, et al.Postconditioning of the lower limb--protection against the reperfusion syndrome. J Surg Res. 2011;169(1):139-147. doi:10.1016/j.jss.2009.10.014
121.
McAllisterSEAshrafpourHCahoonN, et al.Postconditioning for salvage of ischemic skeletal muscle from reperfusion injury: efficacy and mechanism. Am J Physiol Regul Integr Comp Physiol. 2008;295(2):R681-R689. doi:10.1152/ajpregu.90303.2008
122.
WangWWangYYangJ. Protective effects of ischemic postconditioning on skeletal muscle following crush syndrome in the rat. Acta Cir Bras. 2021;36(7):e360701. doi:10.1590/ACB360701
123.
MansourZCharlesALBouitbirJ, et al.Remote and local ischemic postconditioning further impaired skeletal muscle mitochondrial function after ischemia-reperfusion. J Vasc Surg. 2012;56(3):774.e1-782.e1. doi:10.1016/j.jvs.2012.01.079
124.
LintzJADalioMBJovilianoEEPiccinatoCE. Ischemic pre and postconditioning in skeletal muscle injury produced by ischemia and reperfusion in rats. Acta Cir Bras. 2013;28(6):441-446. doi:10.1590/s0102-86502013000600007
125.
FeyzizadehSBadalzadehR. Application of ischemic postconditioning’s algorithms in tissues protection: response to methodological gaps in preclinical and clinical studies. J Cell Mol Med. 2017;21(10):2257-2267. doi:10.1111/jcmm.13159
126.
PedriniLPisanoECatizoneL, et al.Local haemofiltration with free radical scavenger treatment during revascularisation of severe muscular ischaemia induced in sheep limbs. Eur J Vasc Surg. 1992;6(1):47-52. doi:10.1016/s0950-821x(05)80094-5
DickFLiJGiraudMNKalkaCSchmidliJTevaearaiH. Basic control of reperfusion effectively protects against reperfusion injury in a realistic rodent model of acute limb ischemia. Circulation. 2008;118(19):1920-1928. doi:10.1161/CIRCULATIONAHA.108.787754
129.
MessnerFThurnerMMüllerJ, et al.Myogenic progenitor cell transplantation for muscle regeneration following hindlimb ischemia and reperfusion. Stem Cell Res Ther. 2021;12(1):146. doi:10.1186/s13287-021-02208-w
130.
MontelioneNLoreniFNennaA, et al.Tissue engineering and targeted drug delivery in cardiovascular disease: the role of polymer nanocarrier for statin therapy. Biomedicines. 2023;11(3):798. doi:10.3390/biomedicines11030798
131.
NennaANappiFLarobinaDVerghiEChelloMAmbrosioL. Polymers and nanoparticles for statin delivery: current use and future perspectives in cardiovascular disease. Polymers. 2021;13(5):711. doi:10.3390/polym13050711
132.
YuGZRamasamyTFazzariMChenXFreemanBPacellaJJ. Lipid nitroalkene nanoparticles for the focal treatment of ischemia reperfusion. Nanotheranostics. 2022;6(2):215-229. doi:10.7150/ntno.62351
